申请人:Riken
公开号:US07615628B2
公开(公告)日:2009-11-10
The present invention relates to a novel imidazo[4,5-b]pyridine derivative compound represented by Formula (I) and a pharmaceutically acceptable salt thereof. The present invention also relates to a method for preparing the above compound. The present invention further relates to a pharmaceutical composition comprising the above compound. The above compound has growth inhibitory activity on cancer cells, and this effect is dissociated from growth inhibitory activity on normal cells. This indicates that the compound is useful as a novel anticancer agent.
本发明涉及一种新型咪唑[4,5-b]吡啶衍生物化合物,其表示为公式(I)及其药学上可接受的盐。本发明还涉及一种制备上述化合物的方法。本发明进一步涉及一种包含上述化合物的药物组合物。上述化合物对癌细胞具有生长抑制活性,且该效果与对正常细胞的生长抑制活性分离。这表明该化合物可用作一种新型抗癌剂。